PRIMMO study protocol: a phase II study combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancer.

Sandra TuyaertsAn M T Van NuffelEline NaertPeter A Van DamPeter VuylstekeAlex De CaluwéSandrine AspeslaghPiet DirixLien LippensEmiel De JaeghereFrédéric AmantKatrien VandecasteeleHannelore Denys

Published in: BMC cancer (2019)

EU Clinical Trials Register: EudraCT 2016-001569-97 , registered on 19-6-2017. Clinicaltrials.gov: NCT03192059 , registered on 19-6-2017.

Keyphrases

phase ii study
clinical trial
open label
study protocol
papillary thyroid
phase ii
locally advanced
randomized controlled trial
placebo controlled
phase iii
squamous cell
double blind
radiation therapy
radiation induced
squamous cell carcinoma
young adults